AXA Framlington Biotech Fund - Z Accumulation
UMushroom community rating:
0.00
0 votes
No rating yet
NegativeNeutralPositive
General Objective
The aim of this Fund is to provide long-term capital growth over a period of 5 years or more.
Fund Exposure
The Fund invests in shares of listed companies in the biotechnology, genomic, and medical research industry, with a focus on companies of any size worldwide, but with a bias towards the US market. The fund manager selects investments based on financial status, management quality, expected profitability, and growth prospects.
Risks
Investing in shares of listed companies, especially in a specific industry like biotechnology, can be subject to market volatility and specific sector risks. Additionally, the Fund's performance may be influenced by factors affecting the biotechnology sector globally.